CDYL and non-small cell lung carcinoma: Chromodomain Y‐like (CDYL) was reported to indicate a poor prognosis and enhance the chemoresistance in small cell lung cancer.26 We herein found that upregulation of CDYL was associated with poor survival in NSCLC and acted as a direct target of miR‐101‐3p in NSCLC cells.